speb/financial-data huggingface dataset:
SCYX income_statement (annual, 2024-12-31) — EBITDA: -20309000.00
SCYX cash_flow (annual, 2024-12-31) — End Cash Position: 16595000.00
SCYX cash_flow (annual, 2024-12-31) — Financing Cash Flow: -139000.00
SCYX cash_flow (annual, 2024-12-31) — Free Cash Flow: -24009000.00
SCYX cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -14008000.00
SCYX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 14008000.00
SCYX balance_sheet (annual, 2024-12-31) — Gross PPE: 2090000.00
SCYX income_statement (annual, 2024-12-31) — Gross Profit: 3746000.00
SCYX income_statement (quarterly, 2024-12-31) — Gross Profit: 977000.00
SCYX balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 15846000.00
SCYX income_statement (annual, 2024-12-31) — Interest Expense: 828000.00
SCYX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 828000.00
SCYX income_statement (annual, 2024-12-31) — Interest Income: 4291000.00
SCYX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 4291000.00
SCYX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 840000.00
SCYX balance_sheet (annual, 2024-12-31) — Invested Capital: 68765000.00
SCYX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 6150000.00
SCYX balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 15846000.00
SCYX balance_sheet (annual, 2024-12-31) — Investments And Advances: 15846000.00
SCYX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
SCYX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2175000.00
SCYX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2175000.00
SCYX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
SCYX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
SCYX income_statement (annual, 2024-12-31) — Net Income: -21288000.00
SCYX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -21288000.00
SCYX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -21288000.00
SCYX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -21288000.00
SCYX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -21288000.00
SCYX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -21288000.00
SCYX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -21288000.00
SCYX income_statement (annual, 2024-12-31) — Net Interest Income: 1737000.00
SCYX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 6150000.00
SCYX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
SCYX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
SCYX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1737000.00
SCYX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -195000.00
SCYX cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -155000.00
SCYX balance_sheet (annual, 2024-12-31) — Net PPE: 2090000.00
SCYX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 55077000.00
SCYX balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 417000.00
SCYX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1294000.00
SCYX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 1294000.00
SCYX balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 1294000.00
SCYX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 1294000.00
SCYX income_statement (annual, 2024-12-31) — Normalized EBITDA: -34317000.00
SCYX income_statement (annual, 2024-12-31) — Normalized Income: -32354320.00
SCYX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -24009000.00
SCYX cash_flow (annual, 2024-12-31) — Operating Gains Losses: -14008000.00
SCYX income_statement (annual, 2024-12-31) — Operating Income: -37117000.00
SCYX income_statement (annual, 2024-12-31) — Operating Revenue: 3746000.00
SCYX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4746748.00
SCYX balance_sheet (annual, 2024-12-31) — Other Current Assets: 1234000.00
SCYX balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 13688000.00
SCYX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 13688000.00
SCYX income_statement (annual, 2024-12-31) — Other Income Expense: 14243000.00
SCYX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1998000.00
SCYX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 109000.00
SCYX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 235000.00
SCYX balance_sheet (annual, 2024-12-31) — Other Properties: 2090000.00
SCYX balance_sheet (annual, 2024-12-31) — Other Receivables: 10262000.00
SCYX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 10262000.00
SCYX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 43249000.00
SCYX balance_sheet (annual, 2024-12-31) — Payables: 4569000.00
SCYX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 6599000.00
SCYX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1763000.00
SCYX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
SCYX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 950000.00
SCYX income_statement (annual, 2024-12-31) — Pretax Income: -21137000.00
SCYX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 56000.00
SCYX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -36417000.00
SCYX balance_sheet (annual, 2024-12-31) — Receivables: 10262000.00
SCYX balance_sheet (quarterly, 2024-12-31) — Receivables: 10262000.00
SCYX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
SCYX income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
SCYX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 0.00
SCYX income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 0.00
SCYX cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
SCYX income_statement (annual, 2024-12-31) — Research And Development: 26405000.00
SCYX balance_sheet (annual, 2024-12-31) — Restricted Cash: 435000.00
SCYX balance_sheet (annual, 2024-12-31) — Retained Earnings: -376535000.00
SCYX cash_flow (annual, 2024-12-31) — Sale Of Investment: 42567000.00
SCYX income_statement (annual, 2024-12-31) — Selling General And Administration: 14458000.00
SCYX balance_sheet (annual, 2024-12-31) — Share Issued: 4746748.00
SCYX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3346000.00
SCYX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 55077000.00
SCYX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 55077000.00
SCYX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 2941680.00
SCYX income_statement (annual, 2024-12-31) — Tax Provision: 151000.00
SCYX income_statement (quarterly, 2024-12-31) — Tax Provision: 23000.00
SCYX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
SCYX balance_sheet (annual, 2024-12-31) — Total Assets: 90643000.00
SCYX balance_sheet (annual, 2024-12-31) — Total Capitalization: 55077000.00
SCYX balance_sheet (annual, 2024-12-31) — Total Debt: 16270000.00
SCYX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 55077000.00
SCYX income_statement (annual, 2024-12-31) — Total Expenses: 40863000.00
SCYX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 35566000.00
SCYX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 18462000.00
SCYX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 11467000.00
SCYX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -37117000.00
SCYX income_statement (annual, 2024-12-31) — Total Other Finance Cost: 1726000.00
SCYX income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 464000.00
SCYX income_statement (annual, 2024-12-31) — Total Unusual Items: 14008000.00
SCYX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 14008000.00
SCYX balance_sheet (annual, 2024-12-31) — Working Capital: 48082000.00
SCYX income_statement (quarterly, 2025-03-31) — +Operating Expense: 8867000.00
SCYX income_statement (quarterly, 2025-03-31) — +Total Revenue: 257000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4260000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 432416000.00
SCYX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -199000.00
SCYX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 6179437.00
SCYX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.88
SCYX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 16595000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2487000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 42000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 6942000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 40607000.00
SCYX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -14084000.00
SCYX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 12440000.00
SCYX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -7465000.00
SCYX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -199000.00
SCYX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -1163000.00
SCYX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -95000.00
SCYX cash_flow (quarterly, 2025-03-31) — Change In Payable: -199000.00
SCYX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1362000.00
SCYX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 765000.00
SCYX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 537000.00
SCYX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -155000.00
SCYX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -9109000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Common Stock: 42000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 50532000.00
SCYX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
SCYX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2153000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Current Assets: 52221000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 425000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 425000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1642000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1642000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 8957000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 5070000.00
SCYX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 6179437.00
SCYX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.88
SCYX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -5391000.00
SCYX income_statement (quarterly, 2025-03-31) — EBIT: -5218000.00
SCYX income_statement (quarterly, 2025-03-31) — EBITDA: -5218000.00
SCYX cash_flow (quarterly, 2025-03-31) — End Cash Position: 7486000.00
SCYX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -14084000.00
SCYX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -7465000.00
SCYX cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -2928000.00
SCYX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 2928000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2013000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 13155000.00
SCYX income_statement (quarterly, 2025-03-31) — Interest Expense: 173000.00
SCYX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 173000.00
SCYX income_statement (quarterly, 2025-03-31) — Interest Income: 776000.00
SCYX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 776000.00
SCYX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 420000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 50532000.00
SCYX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 12440000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 13155000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 13155000.00
SCYX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
SCYX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2062000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2062000.00
SCYX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -14000000.00
SCYX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
SCYX income_statement (quarterly, 2025-03-31) — Net Income: -5391000.00
SCYX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -5391000.00
SCYX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -5391000.00
SCYX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -5391000.00
SCYX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -5391000.00
SCYX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -5391000.00
SCYX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -5391000.00
SCYX income_statement (quarterly, 2025-03-31) — Net Interest Income: 291000.00
SCYX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 12440000.00
SCYX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -14000000.00
SCYX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -14000000.00
SCYX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 291000.00
SCYX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -110000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Net PPE: 2013000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 50532000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 417000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1294000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 1294000.00
SCYX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -8146000.00
SCYX income_statement (quarterly, 2025-03-31) — Normalized Income: -8319000.00
SCYX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -7465000.00
SCYX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2928000.00
SCYX income_statement (quarterly, 2025-03-31) — Operating Income: -8610000.00
SCYX income_statement (quarterly, 2025-03-31) — Operating Revenue: 257000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 4877534.00
SCYX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 891000.00
SCYX income_statement (quarterly, 2025-03-31) — Other Income Expense: 2928000.00
SCYX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 389000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 109000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Other Properties: 2013000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 9725000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 33665000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Payables: 4260000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 6413000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 477000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
SCYX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 563000.00
SCYX income_statement (quarterly, 2025-03-31) — Pretax Income: -5391000.00
SCYX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 26000.00
SCYX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
SCYX balance_sheet (quarterly, 2025-03-31) — Receivables: 9725000.00
SCYX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -14000000.00
SCYX income_statement (quarterly, 2025-03-31) — Research And Development: 5141000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 435000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -381926000.00
SCYX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 12440000.00
SCYX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3726000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Share Issued: 4877534.00
SCYX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 819000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 50532000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 50532000.00
SCYX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SCYX income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
SCYX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
SCYX balance_sheet (quarterly, 2025-03-31) — Total Assets: 67915000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 50532000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Total Debt: 2487000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 50532000.00
SCYX income_statement (quarterly, 2025-03-31) — Total Expenses: 8867000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 17383000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 15694000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 8426000.00
SCYX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -8610000.00
SCYX income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 312000.00
SCYX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 2928000.00
SCYX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 2928000.00
SCYX balance_sheet (quarterly, 2025-03-31) — Working Capital: 43264000.00
SCYX income_statement (quarterly, 2025-06-30) — +Operating Expense: 10925000.00
SCYX income_statement (quarterly, 2025-06-30) — +Total Revenue: 1364000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 6172000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 433236000.00
SCYX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -115000.00
SCYX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 6218614.00
SCYX income_statement (quarterly, 2025-06-30) — Basic EPS: -1.12
SCYX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 7486000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2389000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 42000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 11020000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 44785000.00
SCYX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
SCYX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 11273000.00
SCYX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -7495000.00
SCYX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1912000.00
SCYX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -153000.00
SCYX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -98000.00
SCYX cash_flow (quarterly, 2025-06-30) — Change In Payable: 1912000.00
SCYX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1759000.00
SCYX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 38000.00
SCYX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -275000.00
SCYX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 772000.00
SCYX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 3778000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Common Stock: 42000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 44467000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1643000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Current Assets: 56498000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 444000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 444000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1770000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1770000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 10863000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 2904000.00
SCYX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 6218614.00
SCYX income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.12
SCYX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -6885000.00
SCYX income_statement (quarterly, 2025-06-30) — EBIT: -6885000.00
SCYX income_statement (quarterly, 2025-06-30) — EBITDA: -6885000.00
SCYX cash_flow (quarterly, 2025-06-30) — End Cash Position: 11264000.00
SCYX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
SCYX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -7495000.00
SCYX cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -2166000.00
SCYX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 2166000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1934000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 1736000.00
SCYX income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
SCYX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
SCYX income_statement (quarterly, 2025-06-30) — Interest Income: 510000.00
SCYX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 510000.00
SCYX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
SCYX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 44467000.00
SCYX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 11273000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 1736000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1736000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1945000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1945000.00
SCYX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
SCYX income_statement (quarterly, 2025-06-30) — Net Income: -6885000.00
SCYX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -6885000.00
SCYX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -6885000.00
SCYX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -6885000.00
SCYX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -6885000.00
SCYX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -6885000.00
SCYX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -6885000.00
SCYX income_statement (quarterly, 2025-06-30) — Net Interest Income: 510000.00
SCYX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 11273000.00
SCYX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
SCYX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
SCYX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 510000.00
SCYX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
SCYX balance_sheet (quarterly, 2025-06-30) — Net PPE: 1934000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 44467000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 417000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 515000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 515000.00
SCYX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -9051000.00
SCYX income_statement (quarterly, 2025-06-30) — Normalized Income: -9051000.00
SCYX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -7495000.00
SCYX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -2166000.00
SCYX income_statement (quarterly, 2025-06-30) — Operating Income: -9561000.00
SCYX income_statement (quarterly, 2025-06-30) — Operating Revenue: 1364000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4896867.00
SCYX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 867000.00
SCYX income_statement (quarterly, 2025-06-30) — Other Income Expense: 2166000.00
SCYX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 79000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 109000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Other Properties: 1934000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 10000000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 33765000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Payables: 6172000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 7815000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 834000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
SCYX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 711000.00
SCYX income_statement (quarterly, 2025-06-30) — Pretax Income: -6885000.00
SCYX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
SCYX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
SCYX balance_sheet (quarterly, 2025-06-30) — Receivables: 10000000.00
SCYX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
SCYX income_statement (quarterly, 2025-06-30) — Research And Development: 7141000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 135000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -388811000.00
SCYX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 11273000.00
SCYX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3784000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Share Issued: 4896867.00
SCYX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 820000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 44467000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 44467000.00
SCYX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SCYX income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
SCYX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
SCYX balance_sheet (quarterly, 2025-06-30) — Total Assets: 60694000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 44467000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Total Debt: 2389000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 44467000.00
SCYX income_statement (quarterly, 2025-06-30) — Total Expenses: 10925000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 16227000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4196000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 5364000.00
SCYX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -9561000.00
SCYX income_statement (quarterly, 2025-06-30) — Total Unusual Items: 2166000.00
SCYX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 2166000.00
SCYX balance_sheet (quarterly, 2025-06-30) — Working Capital: 45635000.00
SCYX income_statement (quarterly, 2025-09-30) — +Operating Expense: 8739000.00
SCYX income_statement (quarterly, 2025-09-30) — +Total Revenue: 334000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3467000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 433787000.00
SCYX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -98000.00
SCYX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 6237361.00
SCYX income_statement (quarterly, 2025-09-30) — Basic EPS: -1.36
SCYX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 11264000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2284000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 45000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 14797000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 37928000.00
SCYX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 29000.00
SCYX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 12417000.00
SCYX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -8724000.00
SCYX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -2705000.00
SCYX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 297000.00
SCYX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -105000.00
SCYX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 287000.00
SCYX cash_flow (quarterly, 2025-09-30) — Change In Payable: -2705000.00
SCYX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -2408000.00
SCYX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 942000.00
SCYX cash_flow (quarterly, 2025-09-30) — Change In Receivables: 0.00
SCYX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1284000.00
SCYX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 3722000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Common Stock: 45000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 36430000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1599000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Current Assets: 48694000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 463000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 463000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1765000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1765000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 8469000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 3544000.00
SCYX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 6237361.00
SCYX income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.36
SCYX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -8591000.00
SCYX income_statement (quarterly, 2025-09-30) — EBIT: -8591000.00
SCYX income_statement (quarterly, 2025-09-30) — EBITDA: -8591000.00
SCYX cash_flow (quarterly, 2025-09-30) — End Cash Position: 14986000.00
SCYX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 29000.00
SCYX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -8724000.00
SCYX cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 640000.00
SCYX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -640000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1851000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 0.00
SCYX income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
SCYX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
SCYX income_statement (quarterly, 2025-09-30) — Interest Income: 454000.00
SCYX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 454000.00
SCYX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
SCYX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 36430000.00
SCYX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 12417000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 0.00
SCYX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 0.00
SCYX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1821000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1821000.00
SCYX income_statement (quarterly, 2025-09-30) — Net Income: -8591000.00
SCYX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -8591000.00
SCYX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -8591000.00
SCYX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -8591000.00
SCYX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -8591000.00
SCYX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -8591000.00
SCYX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -8591000.00
SCYX income_statement (quarterly, 2025-09-30) — Net Interest Income: 454000.00
SCYX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 12417000.00
SCYX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
SCYX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 454000.00
SCYX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
SCYX balance_sheet (quarterly, 2025-09-30) — Net PPE: 1851000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 36430000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 417000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 807000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 807000.00
SCYX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -7951000.00
SCYX income_statement (quarterly, 2025-09-30) — Normalized Income: -7951000.00
SCYX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -8724000.00
SCYX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 640000.00
SCYX income_statement (quarterly, 2025-09-30) — Operating Income: -8405000.00
SCYX income_statement (quarterly, 2025-09-30) — Operating Revenue: 334000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 5244590.00
SCYX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 195000.00
SCYX income_statement (quarterly, 2025-09-30) — Other Income Expense: -640000.00
SCYX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 83000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 109000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Other Properties: 1851000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Other Receivables: 10000000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 23131000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Payables: 3467000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 5066000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1175000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
SCYX balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 491000.00
SCYX income_statement (quarterly, 2025-09-30) — Pretax Income: -8591000.00
SCYX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 25000.00
SCYX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
SCYX balance_sheet (quarterly, 2025-09-30) — Receivables: 10000000.00
SCYX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
SCYX income_statement (quarterly, 2025-09-30) — Research And Development: 5452000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 80000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -397402000.00
SCYX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 12417000.00
SCYX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3287000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Share Issued: 5244590.00
SCYX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 526000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 36430000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 36430000.00
SCYX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SCYX income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
SCYX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
SCYX balance_sheet (quarterly, 2025-09-30) — Total Assets: 51071000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 36430000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Total Debt: 2284000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 36430000.00
SCYX income_statement (quarterly, 2025-09-30) — Total Expenses: 8739000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 14641000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2377000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6172000.00
SCYX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -8405000.00
SCYX income_statement (quarterly, 2025-09-30) — Total Unusual Items: -640000.00
SCYX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -640000.00
SCYX balance_sheet (quarterly, 2025-09-30) — Working Capital: 40225000.00
SCYX income_statement (annual, 2025-12-31) — +Operating Expense: 36675000.00
SCYX income_statement (quarterly, 2025-12-31) — +Operating Expense: 8125000.00
SCYX income_statement (annual, 2025-12-31) — +Total Revenue: 417226.99
SCYX income_statement (quarterly, 2025-12-31) — +Total Revenue: 377632.86
SCYX balance_sheet (annual, 2025-12-31) — Accounts Payable: 2225000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2225000.00
SCYX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 434474000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 434474000.00
SCYX cash_flow (annual, 2025-12-31) — Amortization Of Securities: -474000.00
SCYX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -62000.00
SCYX income_statement (annual, 2025-12-31) — Basic Average Shares: 6241672.00
SCYX income_statement (annual, 2025-12-31) — Basic EPS: -1.36
SCYX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 16595000.00
SCYX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 14986000.00
SCYX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2175000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2175000.00
SCYX balance_sheet (annual, 2025-12-31) — Capital Stock: 46000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 46000.00
SCYX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 21259000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 21259000.00
SCYX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 40031000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 40031000.00
SCYX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -14170000.00
SCYX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -115000.00
SCYX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 24306000.00
SCYX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11824000.00
SCYX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5283000.00
SCYX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 18401000.00
SCYX cash_flow (annual, 2025-12-31) — Change In Account Payable: -2234000.00
SCYX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1242000.00
SCYX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -1002000.00
SCYX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 17000.00
SCYX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -407000.00
SCYX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -109000.00
SCYX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -2702000.00
SCYX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -2337000.00
SCYX cash_flow (annual, 2025-12-31) — Change In Payable: -2234000.00
SCYX cash_flow (quarterly, 2025-12-31) — Change In Payable: -1242000.00
SCYX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -3236000.00
SCYX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -1225000.00
SCYX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 2166000.00
SCYX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 421000.00
SCYX cash_flow (annual, 2025-12-31) — Change In Receivables: 10262000.00
SCYX cash_flow (quarterly, 2025-12-31) — Change In Receivables: 10000000.00
SCYX cash_flow (annual, 2025-12-31) — Change In Working Capital: 6083000.00
SCYX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 6750000.00
SCYX cash_flow (annual, 2025-12-31) — Changes In Cash: 4853000.00
SCYX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 6462000.00
SCYX balance_sheet (annual, 2025-12-31) — Common Stock: 46000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Common Stock: 46000.00
SCYX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 49376000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 49376000.00
SCYX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 5000.00
SCYX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1000.00
SCYX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1284000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1284000.00
SCYX balance_sheet (annual, 2025-12-31) — Current Assets: 40374000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Current Assets: 40374000.00
SCYX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 483000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 483000.00
SCYX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 483000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 483000.00
SCYX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 235000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 235000.00
SCYX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 235000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 235000.00
SCYX balance_sheet (annual, 2025-12-31) — Current Liabilities: 5734000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 5734000.00
SCYX balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 2225000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 2225000.00
SCYX income_statement (annual, 2025-12-31) — Diluted Average Shares: 6241672.00
SCYX income_statement (annual, 2025-12-31) — Diluted EPS: -1.36
SCYX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -8609000.00
SCYX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 12258000.00
SCYX income_statement (annual, 2025-12-31) — EBIT: -8436000.00
SCYX income_statement (quarterly, 2025-12-31) — EBIT: 12258000.00
SCYX income_statement (annual, 2025-12-31) — EBITDA: -8436000.00
SCYX income_statement (quarterly, 2025-12-31) — EBITDA: 12258000.00
SCYX cash_flow (annual, 2025-12-31) — End Cash Position: 21448000.00
SCYX cash_flow (quarterly, 2025-12-31) — End Cash Position: 21448000.00
SCYX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -14170000.00
SCYX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -115000.00
SCYX cash_flow (annual, 2025-12-31) — Free Cash Flow: -5283000.00
SCYX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 18401000.00
SCYX cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -5773000.00
SCYX cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -1319000.00
SCYX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 5773000.00
SCYX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 1319000.00
SCYX balance_sheet (annual, 2025-12-31) — Gross PPE: 1764000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1764000.00
SCYX balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 16247000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 16247000.00
SCYX income_statement (annual, 2025-12-31) — Interest Expense: 173000.00
SCYX income_statement (quarterly, 2025-12-31) — Interest Expense: 0.00
SCYX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 173000.00
SCYX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 0.00
SCYX income_statement (annual, 2025-12-31) — Interest Income: 2177000.00
SCYX income_statement (quarterly, 2025-12-31) — Interest Income: 418000.00
SCYX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2177000.00
SCYX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 418000.00
SCYX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 420000.00
SCYX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
SCYX balance_sheet (annual, 2025-12-31) — Invested Capital: 49376000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 49376000.00
SCYX cash_flow (annual, 2025-12-31) — Investing Cash Flow: 24306000.00
SCYX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -11824000.00
SCYX balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 16247000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 16247000.00
SCYX balance_sheet (annual, 2025-12-31) — Investments And Advances: 16247000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 16247000.00
SCYX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 5000.00
SCYX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1000.00
SCYX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1692000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1692000.00
SCYX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1692000.00
SCYX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1692000.00
SCYX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -14000000.00
SCYX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 5000.00
SCYX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1000.00
SCYX income_statement (annual, 2025-12-31) — Net Income: -8609000.00
SCYX income_statement (quarterly, 2025-12-31) — Net Income: 12258000.00
SCYX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -8609000.00
SCYX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 12258000.00
SCYX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -8609000.00